Loading clinical trials...
Loading clinical trials...
The investigators will test the validity of biomarkers for the detection of heavy alcohol use in patients with and without liver disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
NCT06472973 · Alcohol Associated Liver Disease, Liver Transplantation
NCT05330923 · Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and more
NCT07280390 · Cirrhosis, Microplastics, and more
NCT07588854 · Chronic Liver Disease (CLD), Liver Fibrosis
NCT07143968 · MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, HIV (Human Immunodeficiency Virus)
UZ Leuven
Leuven, Vlaams Brabant
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions